Panbela Therapeutics Est. EPS Q/Q
What is the Est. EPS Q/Q of Panbela Therapeutics?
The Est. EPS Q/Q of Panbela Therapeutics Inc. is 37.50%
What is the definition of Est. EPS Q/Q?
Prospective quarterly EPS growth rate, year over year, is the estimated increase of the company’s EPS for the current quarter compared to performance from a past corresponding quarter.
= current quarter yoy (year over year)
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Est. EPS Q/Q of companies in the Health Care sector on NASDAQ compared to Panbela Therapeutics
What does Panbela Therapeutics do?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Companies with est. eps q/q similar to Panbela Therapeutics
- AMN Healthcare Services has Est. EPS Q/Q of 36.99%
- Canoo has Est. EPS Q/Q of 37.14%
- CVB has Est. EPS Q/Q of 37.14%
- Redington (India) has Est. EPS Q/Q of 37.17%
- Marvell Technology Inc has Est. EPS Q/Q of 37.21%
- Mercedes-Benz AG has Est. EPS Q/Q of 37.33%
- Panbela Therapeutics has Est. EPS Q/Q of 37.50%
- Ashtead Plc has Est. EPS Q/Q of 37.68%
- Xilinx has Est. EPS Q/Q of 37.68%
- Colgate-Palmolive (India) has Est. EPS Q/Q of 37.79%
- Münchener Rückversicherungs-Gesellschaft AG has Est. EPS Q/Q of 37.80%
- Costamare Inc has Est. EPS Q/Q of 37.88%
- Colliers International has Est. EPS Q/Q of 37.89%